Abstract β-Nitro-α-amino acids, that are readily accessible through either the reaction of bromoglycine derivatives with alkyl nitronates or the three-component coupling of amines, nitroalkanes and glyoxalate in aqueous base, are easily converted to the corresponding N-t-Boc-amino acids. These undergo solid-phase Merrifield peptide synthesis, with elimination of nitrous acid, either during or subsequent to cleavage of the peptide from the resin, converting the nitro amino acids to dehydro amino acid residues. The method has been applied successfully with two β,β-disubstituted nitro amino acids and N-methyl-β-nitronorvaline, but failed with β-nitroalanine.
Introduction
Peptides containing α,β-dehydro-α-amino acid residues are of interest as synthetic targets, principally because of the physiological activity of many naturally occurring compounds of this type. 1 Free dehydro amino acids are generally unsuitable for direct peptide synthesis because developing a complementary approach involving the incorporation of β-nitro-α-amino acids in peptides as latent α,β-dehydro-α-amino acid residues. β-Nitro amino acids with a wide variety of side chains are easily prepared through reaction of α-bromoglycine derivatives with alkyl nitronates 6, 7 or, more directly, through the three-component coupling of amines, nitroalkanes and glyoxylate in aqueous base. 8 Previously we have shown that the amino acid tert-butyl esters can be incorporated as the C-terminal residues in N-and C-protected dipeptides, using solution-phase methods. 9 We now report on the utility of the nitro amino acids in solid-phase peptide synthesis, and the isolation and characterization of the free peptides.
Results and Discussion
The β-nitro-α-amino acids used in this study were prepared as shown in Scheme 1. β-Nitroalanine 6a was obtained by treatment of the bromoglycine derivative 1 with methyl nitronate, followed by removal of the protecting groups from the alanine derivative 2 through reaction with trifluoroacetic acid. Resin substituted with N-t-Boc-(S)-phenylalanine 8 was treated with trifluoroacetic acid to remove the N-protecting group. The resin was then washed and neutralized before being treated with the nitrocyclopentylglycine 7c that had been activated by pre-treatment with dicyclohexylcarbodiimide and 1-hydroxybenzotriazole. The cycle of deprotection with trifluoroacetic acid and coupling with an activated amino acid was repeated, this time using N-tBoc-(S)-valine 9. After washing and drying, the resin was treated with hydrogen fluoride/anisole, then the hydrogen fluoride was removed by distillation at 0 °C. The residual solution was separated from the resin and treated with diethyl ether to give a white precipitate, which was subjected to preparative HPLC, to give the tripeptide 11.
In a similar manner, the nitronorvaline derivative 7d and N-t-Boc-(S)-phenylalanine were sequentially coupled to resin substituted with N-t-Boc-O-Bz-(S)-serine. In this case treatment with hydrogen fluoride cleaved the product from the resin as well as removing the benzyl protecting group, to give the tripeptide 12. The assignment of Z-stereochemistry to the dehydronorvaline residue in the tripeptide 12 is made on the basis of the tendency of dehydro amino acid derivatives to favor this configuration. 11 When the same resin was treated with the valine derivative 7b and then N-t-Boc-(S)-phenylalanine, only a trace of the tripeptide 14 was obtained. Instead the diastereomers of the β-nitrovaline derivative 13 were the major components isolated. These were easily converted to the dehydrovaline derivative 14 on treatment with base. When the serine-substituted resin was treated with the nitroalanine 7a and then N-t-Boc-(S)-phenylalanine, neither the tripeptide 15 nor the corresponding β-nitroalanine-containing peptide was obtained. These experiments show that β-nitro-α-amino acids can be used in solid-phase peptide synthesis. Presumably elimination of nitrous acid then occurs under the conditions of cleavage from the resin in the cases of the peptides 11 and 12, the putative precursor of the former being the nitrocyclopentylglycine derivative 10. The method works equally well with the Nunsubstituted and N-methyl amino acid derivatives 7c and 7d, respectively. Elimination of nitrous acid from the nitrovaline derivative 13 is less facile and separate treatment with base is therefore required for the efficient production of the tripeptide 14. The decreased reactivity in this system can be attributed to the increased steric constraints associated with bringing the substituents at the α-and β-positions into coplanarity, during the change in hybridization. 6 By analogy, loss of nitrous acid from β-nitroalanine derivatives is more facile 6 and this may be occurring during the use of the amino acid 7a in peptide synthesis, leading to decomposition of reactive dehydroalanine derivatives and the failure to produce the peptide 15. However, since dehydroalanine derivatives are readily prepared from serine, they are already accessible by methods that are truly complementary to the approach presented here.
Experimental Section
General Procedures. Melting points (mp) were determined on a Kofler hot-stage melting point apparatus under a Reichert microscope and are uncorrected. Microanalyses were performed by the Research School of Chemistry Microanalytical Service at the Australian National University, on a Carlo-Erba 1106 autoanalyser. Nuclear magnetic resonance (NMR) spectra were recorded on a Varian Gemini 300 spectrometer. Proton ( 1 H) NMR spectra were recorded at 300 MHz and carbon ( 13 C) NMR spectra were recorded at 75.5 MHz. Infrared (IR) spectra were recorded as KBr disks on a Perkin-Elmer 1800 infrared spectrophotometer. Electron impact (EI) mass spectra were obtained using a VG Autospec double focussing trisector mass spectrometer. Electrospray (ESI) mass spectra were obtained using a VG Quatro II triple quadrupole mass spectrometer operating in the positive ion mode. β-Nitroalanine 6a, 7 β-nitrovaline 6b, 8 β-nitrocyclopentylglycine 6c 8 and N-methyl-β-nitronorvaline 6d 8d were prepared as reported previously, the latter as a 6:1 mixture of
diastereomers. N-t-Boc-(S)-Phenylalanine and N-t-Boc-(S)-valine 9, and Merrifield polystyrene resins substituted with N-t-Boc-(S)-phenylalanine 8 and N-t-Boc-O-Bz-(S)-serine
were available from Auspep Pty. Ltd. Methanol was dried using sodium. HPLC was performed using a Superspher ® 250-4, LiChroCART, 100 RP-18 column eluting with acetonitrile/water (90/10, v/v) containing 0.1% trifluoroacetic acid.
N-t-Boc-β-nitroalanine (7a).
A mixture of β-nitroalanine 6a (0.47 g, 3.5 mmol), di-t-butyl dicarbonate (1.51 g, 6.9 mmol) and triethylamine (0.56 mL, 4.0 mmol) in dry methanol (5.6 mL) was heated at reflux under a nitrogen atmosphere for 0.5 h, before it was cooled and concentrated under reduced pressure. The residue was partitioned between aqueous hydrochloric acid (0.5 mol dm -3 , 20 mL) and ethyl acetate (20 mL). The aqueous phase was extracted with ethyl acetate (3 × 20 mL) and the combined organic fractions were extracted with aqueous potassium hydroxide (0.5 mol dm -3 , 3 × 40 mL). The combined basic extracts were acidified with aqueous hydrochloric acid (2.0 mol dm -3 ) and the resultant precipitate was collected by filtration, to give the title compound 7a as a colorless solid (0. N-t-Boc-β-nitrovaline (7b). Treatment of β-nitrovaline 6b (0.3 g, 1 .85 mmol) with di-t-butyl dicarbonate (0.81 g, 3.7 mmol), as described above for the synthesis of N-t-Boc-β-nitroalanine 7a, afforded the title compound 7b as a colorless solid (0.24 g, 49%); mp 154-156 °C; 1 
S)-Valyl-α,β-dehydrocyclopentylglycyl-(S)-phenylalanine (11). N-t-Boc-(S)-phenylalanine-
substituted Merrifield polystyrene resin 8 (1.0 g, 1.0 mmol) was shaken with trifluoroacetic acid (20 mL) at room temperature for 0.5 h. The resin was then washed repeatedly with dichloromethane and diisopropylethylamine in dichloromethane (5%, v/v), before it was treated with a solution that had been prepared from N-t-Boc-β-nitrocyclopentylglycine 7c (0.85 g, 2.95 mmol), dicyclohexylcarbo-diimide (0.61 g, 2.95 mmol), 1-hydroxybenzotriazole (0.40 g, 2.95 mmol) and dichloromethane (5 mL). The mixture was shaken at room temperature for 4 h, before the resin was separated and washed with dichloromethane. The cycle of treatment with
